Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Applications of pharmaceutical composition in preparation of drugs for treatment of cerebrovascular diseases and complications thereof

A technology for cerebrovascular disease and composition, which is applied in the application field of pharmaceutical composition as a medicine for the preparation of cerebrovascular disease and its complications, can solve the problem that none of them is better, the treatment effect is not good, and there is no complication treatment. Description of the effect and other issues, to achieve the effect of improving cerebral vascular blood supply, inhibiting platelet aggregation, and non-toxic side effects

Inactive Publication Date: 2016-12-21
HEBEI GOGIN PHARMA
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Application No. 200810232144.4 discloses the application of total saponins of Tribulus terrestris in the preparation of drugs for the treatment of cerebrovascular diseases, and provides a drug for the treatment of cerebrovascular diseases; It is a better therapeutic drug, and some drugs are basically through promoting blood circulation and removing blood stasis, which can slow down the damage of "stasis toxin" of cerebral infarction to a certain extent, comprehensively improve the damaged brain tissue, and thus play a role in neurological function. Protective effect, its therapeutic effect is not good, the present invention uses total saponins of Tribulus terrestris for the treatment of cerebrovascular disease, has opened up a new scheme to the treatment of cerebrovascular disease
[0009] The main problem in the above-mentioned patent documents is: the drug is mainly aimed at cerebrovascular diseases, and there is no description of the therapeutic effect on complications caused by cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of pharmaceutical composition in preparation of drugs for treatment of cerebrovascular diseases and complications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] The pharmaceutical composition is used in the preparation of drugs for the treatment of cerebrovascular diseases and their complications. The pharmaceutical composition in this embodiment is made of crude drugs comprising the following unit mass parts:

[0078] Hawthorn 375; Salvia 375; Pueraria 375; Panax notoginseng 25;

[0079] The above pharmaceutical composition can be formulated into oral capsules in combination with corresponding auxiliary materials.

Embodiment 2

[0081] The pharmaceutical composition of this embodiment can be formulated into oral granules with corresponding auxiliary materials.

Embodiment 3

[0083] The pharmaceutical composition of this embodiment can be formulated into oral powder with corresponding auxiliary materials.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of traditional Chinese medicines, and particularly relates to applications of a pharmaceutical composition in preparation of drugs for treatment of cerebrovascular diseases and complications thereof, wherein the pharmaceutical composition is prepared from the following crude drugs by mass: 375 parts of hawthorn, 375 parts of salvia miltiorrhiza, 375 parts of radix puerariae, 25 parts of panax notoginseng, and 25 parts of common vladimiria root. According to the present invention, the problems that the long-term taking of Western medicines can cause a variety of side effects and the like in the existing treatment means are effectively solved, and the pharmaceutical composition has the good cerebrovascular disease and complication treatment effects compared with the existing drugs, and further has advantages of no toxic-side effect, and the like.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, in particular to the application of a pharmaceutical composition as a medicine for treating cerebrovascular diseases and their complications. Background technique [0002] In recent years, due to the improvement of people's living standards, the incidence of cerebrovascular diseases has increased year by year due to unhealthy lifestyles and emotions, showing a trend of "younger" incidence. [0003] Cerebrovascular disease is a group of diseases with cerebral hemorrhagic or ischemic damage as the main clinical manifestation caused by rupture of cerebral blood vessels or thrombosis on the basis of cerebral arteriosclerosis. One of the leading diseases that cause disability. [0004] Cerebrovascular diseases can be simply divided into two categories, one is ischemic cerebrovascular disease caused by the reduction or interruption of blood flow, and the other is hemorrhagic cerebrovascular...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/734A61P9/10
CPCA61K36/734A61K36/258A61K36/285A61K36/488A61K36/537A61K2300/00
Inventor 张四岩赵国强王建允
Owner HEBEI GOGIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products